EHC Encompass Health
- 84.955
- -0.405-0.47%
Encompass Health News
Here's Why Encompass Health (EHC) Is a Strong Growth Stock
This Encompass Health Insider Reduced Their Stake By 35%
Viewing insider transactions for Encompass Health Corporation's (NYSE:EHC ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders i
Here's Why Encompass Health (EHC) Is a Strong Value Stock
Encompass Health Price Target Maintained With a $94.00/Share by Stephens & Co.
Encompass Health Price Target Maintained With a $94.00/Share by Stephens & Co.
Express News | Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $94 Price Target
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 3, 2024
GAINERS:1933 Industries (OTC:TGIFF) shares closed up 31.87% at $0.01CV Sciences (OTC:CVSI) shares closed up 17.65% at $0.08Eastside Distilling (NASDAQ:EAST) shares closed up 9.80% at $1.04Corbus Pharm
Encompass Health Highlights Non-GAAP Guidance Limitations
Here's How Much $1000 Invested In Encompass Health 15 Years Ago Would Be Worth Today
Encompass Health (NYSE:EHC) has outperformed the market over the past 15 years by 2.8% on an annualized basis producing an average annual return of 14.93%. Currently, Encompass Health has a market cap
Subdued Growth No Barrier To Encompass Health Corporation's (NYSE:EHC) Price
Encompass Health Corporation's (NYSE:EHC) price-to-earnings (or "P/E") ratio of 21.7x might make it look like a sell right now compared to the market in the United States, where around half of the co
Insider Sale: Chief Medical Officer Elissa Charbonneau Sells 10,000 Shares of Encompass Health ...
Encompass Health(EHC.US) Officer Sells US$850.2K in Common Stock
$Encompass Health(EHC.US)$ Officer Charbonneau Elissa Joy sold 10,000 shares of common stock on May 24, 2024 at an average price of $85.02 for a total value of $850.2K.Source: Announcement What is sta
Encompass Health Insider Sold Shares Worth $850,200, According to a Recent SEC Filing
Elissa Joy Charbonneau, Chief Medical Officer, on May 24, 2024, sold 10,000 shares in Encompass Health (EHC) for $850,200. Following the Form 4 filing with the SEC, Charbonneau has control over a tota
Encompass Health (EHC) JV Opens Atlanta Rehabilitation Hospital
Encompass Health to Present at 2024 Leerink Partners Healthcare Crossroads Conference
BIRMINGHAM, Ala., May 23, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the 2024 Leerink Partners Healthcare Crossroads Conference being held in Austi
Rehabilitation Hospital of Atlanta, a 40-bed Inpatient Rehabilitation Hospital, Now Open in Georgia
Piedmont, the largest healthcare system in the state of Georgia, and Encompass Health (NYSE: EHC), the nation's largest owner and operator of...
Form 144 | Encompass Health(EHC.US) Officer Proposes to Sell 2.52 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 22, $Encompass Health(EHC.US)$ Officer CHIDSEY JOHN intends to sell 29,500 shares of its common stock on May 22, with a total market value of approximately $2.52 million.
Encompass Health Poised for 'Solid Progress' on Development Front Due to Discharge Growth, Industry Demand, RBC Says
Encompass Health (EHC) is poised for "solid progress" on the development front as about 33% Q1 discharge growth came from new locations, RBC Capital Markets said in a note Tuesday. "During the quarter
6 Analysts Have This To Say About Encompass Health
6 analysts have expressed a variety of opinions on Encompass Health (NYSE:EHC) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view
Encompass Health Price Target Raised to $95.00/Share From $83.00 by RBC Capital
Encompass Health Price Target Raised to $95.00/Share From $83.00 by RBC Capital
Encompass Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 10.77% RBC Capital $83 → $95 Maintains Outperform 04/26/2024 10.77% Raymond James $85 → $95 Rei
Analysis
Price Target
No Data
